Spinaroo Commercial IPO listed at ₹52.85 on the BSE SME platform on April 8, 2025, marking a 3.63% gain over its issue price of ₹51.
Spinaroo Commercial IPO was subscribed 1.52 times overall, with bids for 28.78 lakh shares against 18.94 lakh offered. Non-institutional buyers subscribed 1.84 times, while retail investors saw a 1.2x subscription. The total bid amount stood at ₹14.68 crore across 713 applications.
Spinaroo Commercial IPO listed at ₹52.85, its issue price of ₹51, exceeding the grey market expectation of ₹51. With the last GMP at ₹0, the IPO saw a neutral grey market sentiment but managed a positive listing.
Overview of Contents
Details About Spinaroo Commercial IPO
Shri Ahimsa Naturals SME IPO is a book-built issue offering a mix of fresh shares and an offer for sale. The company, established in 1990, specializes in extracting and manufacturing natural caffeine, green coffee bean extracts, and crude caffeine. Supplying to industries like food & beverage, nutraceuticals, cosmetics, and pharmaceuticals, it sources crude caffeine from Vietnam and Mexico while also processing caffeine from coffee and tea waste. With exports spanning over 14 countries, including the USA, Germany, South Korea, and the UK, Shri Ahimsa Naturals operates a GMP and HACCP-compliant manufacturing unit in Jaipur. Backed by an experienced management team and strong client relationships, the company aims to leverage its global presence and industry expertise for long-term growth.